Siren, L.L.C. Kymera Therapeutics, Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 3,240,313 shares of KYMR stock, worth $143 Million. This represents 5.05% of its overall portfolio holdings.
Number of Shares
3,240,313
Previous 2,969,733
9.11%
Holding current value
$143 Million
Previous $119 Billion
25.77%
% of portfolio
5.05%
Previous 5.28%
Shares
2 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$296 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$285 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$265 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$265 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$231 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.41B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...